XML 45 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Organization (Details) - USD ($)
$ in Millions
1 Months Ended 9 Months Ended
Nov. 30, 2023
Sep. 30, 2024
Jun. 30, 2023
Jan. 31, 2023
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Aggregate offering price $ 300.0      
Cash, cash equivalents and investments   $ 1,190.0    
Common Stock | Sales Agreement        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Issuance of common stock (in shares)   0    
Common Stock | Sales Agreement | Maximum        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Percentage of commission rate from sale of shares 3.00%      
Encentrio Therapeutics, Inc.        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Percentage of outstanding voting shares owned     100.00%  
Encentrio Therapeutics, Inc.        
Organization Consolidation And Presentation Of Financial Statements [Line Items]        
Percentage of outstanding voting shares owned       80.00%